{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:24:51Z","timestamp":1791473091211,"version":"4.3.4"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesiologie"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00101-023-01354-5","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T17:02:17Z","timestamp":1699635737000},"page":"4-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Leitliniengerechte Therapie der Sepsis","Guideline-conform treatment of sepsis"],"prefix":"10.1007","volume":"73","author":[{"given":"Thomas","family":"Schmoch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Weigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"1354_CR1","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"MH Abdul-Aziz","year":"2020","unstructured":"Abdul-Aziz\u00a0MH, Alffenaar\u00a0J\u2011WC, Bassetti\u00a0M et al (2020) Antimicrobial therapeutic drug monitoring in critically ill adult patients: a\u00a0position paper. Intensive Care Med 46:1127\u20131153. https:\/\/doi.org\/10.1007\/s00134-020-06050-1","journal-title":"Intensive Care Med"},{"key":"1354_CR2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s00134-022-06654-9","volume":"48","author":"MH Alshaer","year":"2022","unstructured":"Alshaer\u00a0MH, Peloquin\u00a0CA (2022) Another trial for the TARGET trial. Intensive Care Med 48:774\u2013775. https:\/\/doi.org\/10.1007\/s00134-022-06654-9","journal-title":"Intensive Care Med"},{"key":"1354_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1056\/NEJMsa1410639","volume":"372","author":"MBP Amato","year":"2015","unstructured":"Amato\u00a0MBP, Meade\u00a0MO, Slutsky\u00a0AS et\u00a0al (2015) Driving pressure and survival in the acute respiratory distress syndrome. N\u00a0Engl J Med 372:747\u2013755. https:\/\/doi.org\/10.1056\/NEJMsa1410639","journal-title":"N Engl J Med"},{"key":"1354_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.2017.10913","volume":"318","author":"B Andrews","year":"2017","unstructured":"Andrews\u00a0B, Semler\u00a0MW, Muchemwa\u00a0L et al (2017) Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a\u00a0randomized clinical trial. JAMA 318:1233\u20131240. https:\/\/doi.org\/10.1001\/jama.2017.10913","journal-title":"JAMA"},{"key":"1354_CR5","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00134-015-3822-1","volume":"41","author":"DC Angus","year":"2015","unstructured":"Angus\u00a0DC, Barnato\u00a0AE, Bell\u00a0D et al (2015) A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med 41:1549\u20131560. https:\/\/doi.org\/10.1007\/s00134-015-3822-1","journal-title":"Intensive Care Med"},{"key":"1354_CR6","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","volume":"371","author":"SL Peake","year":"2014","unstructured":"ARISE Investigators, ANZICS Clinical Trials Group, Peake\u00a0SL et al (2014) Goal-directed resuscitation for patients with early septic shock. N\u00a0Engl J Med 371:1496\u20131506. https:\/\/doi.org\/10.1056\/NEJMoa1404380","journal-title":"N Engl J Med"},{"key":"1354_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s13054-014-0532-y","volume":"18","author":"X Bai","year":"2014","unstructured":"Bai\u00a0X, Yu\u00a0W, Ji\u00a0W et\u00a0al (2014) Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care 18:532. https:\/\/doi.org\/10.1186\/s13054-014-0532-y","journal-title":"Crit Care"},{"key":"1354_CR8","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1056\/NEJMoa1803213","volume":"379","author":"SD Barbar","year":"2018","unstructured":"Barbar\u00a0SD, Clere-Jehl\u00a0R, Bourredjem\u00a0A et al (2018) Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N\u00a0Engl J Med 379:1431\u20131442. https:\/\/doi.org\/10.1056\/NEJMoa1803213","journal-title":"N Engl J Med"},{"key":"1354_CR9","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1093\/cid\/cit278","volume":"57","author":"EJ Baron","year":"2013","unstructured":"Baron\u00a0EJ, Miller\u00a0JM, Weinstein\u00a0MP et\u00a0al (2013) A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the infectious diseases society of america (IDSA) and the american society for microbiology (ASM)(a). Clin Infect Dis Off Publ Infect Dis Soc Am 57:e22\u2013e121. https:\/\/doi.org\/10.1093\/cid\/cit278","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"1354_CR10","volume-title":"Rote-Hand-Brief zu HES-haltigen Infusionsl\u00f6sungen: Neue Kontraindikationen und Anwendungsbeschr\u00e4nkungen","author":"Baxter Deutschland GmbH","year":"2013","unstructured":"Baxter Deutschland GmbH, B.\u00a0Braun Melsungen AG, Fresenius Kabi Deutschland GmbH, Serumwerk Bernburg AG (2013) Rote-Hand-Brief zu HES-haltigen Infusionsl\u00f6sungen: Neue Kontraindikationen und Anwendungsbeschr\u00e4nkungen"},{"key":"1354_CR11","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2016.12310","volume":"316","author":"P Bentzer","year":"2016","unstructured":"Bentzer\u00a0P, Griesdale\u00a0DE, Boyd\u00a0J et\u00a0al (2016) Will this Hemodynamically unstable patient respond to a\u00a0bolus of intravenous fluids? JAMA 316:1298\u20131309. https:\/\/doi.org\/10.1001\/jama.2016.12310","journal-title":"JAMA"},{"key":"1354_CR12","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/cc13755","volume":"18","author":"F Bloos","year":"2014","unstructured":"Bloos\u00a0F, Thomas-R\u00fcddel\u00a0D, R\u00fcddel\u00a0H et al (2014) Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a\u00a0prospective observational multi-center study. Crit Care Lond Engl 18:R42. https:\/\/doi.org\/10.1186\/cc13755","journal-title":"Crit Care Lond Engl"},{"key":"1354_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/JCM.36.1.105-109.1998","volume":"36","author":"F Blot","year":"1998","unstructured":"Blot\u00a0F, Schmidt\u00a0E, Nitenberg\u00a0G et al (1998) Earlier positivity of central-venous-versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J\u00a0Clin Microbiol 36:105\u2013109","journal-title":"J Clin Microbiol"},{"key":"1354_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jamainternmed.2023.0258","volume":"183","author":"NA Bosch","year":"2023","unstructured":"Bosch\u00a0NA, Teja\u00a0B, Law\u00a0AC et\u00a0al (2023) Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock. JAMA Intern Med 183:451\u2013459. https:\/\/doi.org\/10.1001\/jamainternmed.2023.0258","journal-title":"JAMA Intern Med"},{"key":"1354_CR15","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1155\/2010\/357076","volume":"21","author":"EJ Bow","year":"2010","unstructured":"Bow\u00a0EJ, Evans\u00a0G, Fuller\u00a0J et\u00a0al (2010) Canadian clinical practice guidelines for invasive candidiasis in adults. Can J Infect Dis Med Microbiol 21:e122\u2013e150 (J Can Mal Infect Microbiol Medicale)","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"1354_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00101-022-01174-z","volume":"71","author":"A Brinkmann","year":"2022","unstructured":"Brinkmann\u00a0A, Frey\u00a0O (2022) Therapeutisches Drugmonitoring und individualisierte Antibiotikadosierung \u2013 \u201eTool or toy\u201c auf der Intensivstation. Anaesthesiol 71:493\u2013494. https:\/\/doi.org\/10.1007\/s00101-022-01174-z","journal-title":"Anaesthesiol"},{"key":"1354_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00063-016-0213-5","volume":"113","author":"A Brinkmann","year":"2018","unstructured":"Brinkmann\u00a0A, R\u00f6hr\u00a0AC, K\u00f6berer\u00a0A et\u00a0al (2018) Therapeutic drug monitoring and individual dosing of antibiotics during sepsis : Modern or just \u201etrendy\u201c?]. Med Klin. Intensivmed Notfallmedizin 113:82\u201393. https:\/\/doi.org\/10.1007\/s00063-016-0213-5","journal-title":"Intensivmed Notfallmedizin"},{"key":"1354_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00063-020-00685-0","volume":"115","author":"FM Brunkhorst","year":"2020","unstructured":"Brunkhorst\u00a0FM, Weigand\u00a0MA, Pletz\u00a0M et al (2020) S3 guideline sepsis-prevention, diagnosis, therapy, and aftercare: long version. Med Klin Intensivmed Notfmed 115:37\u2013109. https:\/\/doi.org\/10.1007\/s00063-020-00685-0","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"1354_CR19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0854OC","author":"MM Churpek","year":"2016","unstructured":"Churpek\u00a0MM, Snyder\u00a0A, Han\u00a0X et\u00a0al (2016) qSOFA, SIRS, and early warning scores for detecting clinical deterioration in infected patients outside the ICU. Am J Respir Crit Care Med. https:\/\/doi.org\/10.1164\/rccm.201604-0854OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1354_CR20","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1086\/421087","volume":"38","author":"FR Cockerill","year":"2004","unstructured":"Cockerill\u00a0FR, Wilson\u00a0JW, Vetter\u00a0EA et\u00a0al (2004) Optimal testing parameters for blood cultures. Clin Infect Dis Off Publ Infect Dis Soc Am 38:1724\u20131730. https:\/\/doi.org\/10.1086\/421087","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"1354_CR21","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00134-022-06883-y","volume":"48","author":"G De Pascale","year":"2022","unstructured":"De Pascale\u00a0G, Antonelli\u00a0M, Deschepper\u00a0M et\u00a0al (2022) Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis. Intensive Care Med 48:1593\u20131606. https:\/\/doi.org\/10.1007\/s00134-022-06883-y","journal-title":"Intensive Care Med"},{"key":"1354_CR22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215145","author":"P-F Dequin","year":"2023","unstructured":"Dequin\u00a0P\u2011F, Meziani\u00a0F, Quenot\u00a0J\u2011P et al (2023) Hydrocortisone in severe community-acquired pneumonia. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2215145","journal-title":"N Engl J Med"},{"key":"1354_CR23","volume-title":"S3-Leitlinie Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz","author":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin (DGAI)","year":"2017","unstructured":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin (DGAI) (2017) S3-Leitlinie Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz"},{"key":"1354_CR24","volume-title":"S3-Leitlinie Sepsis \u2013 Pr\u00e4vention, Diagnose, Therapie und Nachsorge","author":"F Brunkhorst","year":"2018","unstructured":"Deutsche Sepsis Gesellschaft e.\u202fV. (federf\u00fchrend), Brunkhorst\u00a0F, Weigand\u00a0MA (2018) S3-Leitlinie Sepsis \u2013 Pr\u00e4vention, Diagnose, Therapie und Nachsorge"},{"key":"1354_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.01.008","author":"KM D\u2019Silva","year":"2021","unstructured":"D\u2019Silva\u00a0KM, Mehta\u00a0R, Mitchell\u00a0M et al (2021) Proton pump inhibitor use and risk for recurrent clostridioides difficile infection: a\u00a0systematic review and meta-analysis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. https:\/\/doi.org\/10.1016\/j.cmi.2021.01.008 (S1198\u2013743X(21)00035\u20135)","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"1354_CR26","doi-asserted-by":"publisher","DOI":"10.1055\/a-0790-6453","author":"G Elke","year":"2018","unstructured":"Elke\u00a0G, Hartl\u00a0WH, Kreymann\u00a0KG et al (2018) Erratum: DGEM-Leitlinie: \u201eKlinische Ern\u00e4hrung in der Intensivmedizin\u201c. Aktuel Ernahrungsmed. https:\/\/doi.org\/10.1055\/a-0790-6453","journal-title":"Aktuel Ernahrungsmed"},{"key":"1354_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1055\/a-0805-4118","volume":"54","author":"G Elke","year":"2019","unstructured":"Elke\u00a0G, Hartl\u00a0WH, Kreymann\u00a0KG et\u00a0al (2019) DGEM guideline \u201eclinical nutrition in critical care medicine\u201c\u2014short version]. Anasthesiologie Intensivmed Notfallmedizin Schmerzther. AINS 54:63\u201373. https:\/\/doi.org\/10.1055\/a-0805-4118","journal-title":"AINS"},{"key":"1354_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","author":"L Evans","year":"2021","unstructured":"Evans\u00a0L, Rhodes\u00a0A, Alhazzani\u00a0W et\u00a0al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"1354_CR29","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","volume":"118","author":"H Foley Jonathan","year":"2016","unstructured":"Foley Jonathan\u00a0H, Edward\u00a0CM (2016) Cross talk pathways between coagulation and inflammation. Circ Res 118:1392\u20131408. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.306853","journal-title":"Circ Res"},{"key":"1354_CR30","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","volume":"372","author":"J-P Frat","year":"2015","unstructured":"Frat\u00a0J\u2011P, Thille\u00a0AW, Mercat\u00a0A et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N\u00a0Engl J Med 372:2185\u20132196. https:\/\/doi.org\/10.1056\/NEJMoa1503326","journal-title":"N Engl J Med"},{"key":"1354_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003709.pub4","author":"G Gamper","year":"2016","unstructured":"Gamper\u00a0G, Havel\u00a0C, Arrich\u00a0J et\u00a0al (2016) Vasopressors for hypotensive shock. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD003709.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"1354_CR32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/jac\/dkm460","volume":"61","author":"J Garnacho-Montero","year":"2008","unstructured":"Garnacho-Montero\u00a0J, Ortiz-Leyba\u00a0C, Herrera-Melero\u00a0I et al (2008) Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a\u00a0matched cohort study. J\u00a0Antimicrob Chemother 61:436\u2013441. https:\/\/doi.org\/10.1093\/jac\/dkm460","journal-title":"J Antimicrob Chemother"},{"key":"1354_CR33","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1001\/jama.2016.11993","volume":"316","author":"M Girardis","year":"2016","unstructured":"Girardis\u00a0M, Busani\u00a0S, Damiani\u00a0E et al (2016) Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the oxygen-ICU randomized clinical trial. JAMA 316:1583\u20131589. https:\/\/doi.org\/10.1001\/jama.2016.11993","journal-title":"JAMA"},{"key":"1354_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"R Guilhaumou","year":"2019","unstructured":"Guilhaumou\u00a0R, Benaboud\u00a0S, Bennis\u00a0Y et al (2019) Optimization of the treatment with beta-lactam antibiotics in critically ill patients\u2014guidelines from the French society of pharmacology and therapeutics (Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique\u2014SFPT) and the French society of anaesthesia and intensive care medicine (Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et R\u00e9animation\u2014SFAR). Crit Care 23:104. https:\/\/doi.org\/10.1186\/s13054-019-2378-9","journal-title":"Crit Care"},{"key":"1354_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00134-021-06609-6","volume":"48","author":"S Hagel","year":"2022","unstructured":"Hagel\u00a0S, Bach\u00a0F, Brenner\u00a0T et al (2022) Effect of therapeutic drug monitoring-based dose optimization of piperacillin\/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a\u00a0randomized controlled trial. Intensive Care Med 48:311\u2013321. https:\/\/doi.org\/10.1007\/s00134-021-06609-6","journal-title":"Intensive Care Med"},{"key":"1354_CR36","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","volume":"321","author":"G Hern\u00e1ndez","year":"2019","unstructured":"Hern\u00e1ndez\u00a0G, Ospina-Tasc\u00f3n\u00a0GA, Damiani\u00a0LP et al (2019) Effect of a\u00a0resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock. JAMA 321:654\u2013664. https:\/\/doi.org\/10.1001\/jama.2019.0071","journal-title":"JAMA"},{"key":"1354_CR37","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0140-6736(22)02469-2","volume":"401","author":"DK Heyland","year":"2023","unstructured":"Heyland\u00a0DK, Patel\u00a0J, Compher\u00a0C et al (2023) The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trial. The Lancet 401:568\u2013576. https:\/\/doi.org\/10.1016\/S0140-6736(22)02469-2","journal-title":"The Lancet"},{"key":"1354_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13613-019-0530-y","volume":"9","author":"PM Honore","year":"2019","unstructured":"Honore\u00a0PM, Hoste\u00a0E, Moln\u00e1r\u00a0Z et\u00a0al (2019) Cytokine removal in human septic shock: Where are we and where are we going? Ann Intensive Care 9:56. https:\/\/doi.org\/10.1186\/s13613-019-0530-y","journal-title":"Ann Intensive Care"},{"key":"1354_CR39","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa1903297","volume":"382","author":"D Mackle","year":"2020","unstructured":"ICU-ROX Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group, Mackle\u00a0D, Bellomo\u00a0R (2020) Conservative oxygen therapy during mechanical ventilation in the ICU. N\u00a0Engl J Med 382:989\u2013998. https:\/\/doi.org\/10.1056\/NEJMoa1903297","journal-title":"N Engl J Med"},{"key":"1354_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)31080-8","volume":"392","author":"S Jaber","year":"2018","unstructured":"Jaber\u00a0S, Paugam\u00a0C, Futier\u00a0E et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a\u00a0multicentre, open-label, randomised controlled, phase\u00a03\u00a0trial. Lancet Lond Engl 392:31\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(18)31080-8","journal-title":"Lancet Lond Engl"},{"key":"1354_CR41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.chest.2020.08.2068","volume":"159","author":"KE Jackson","year":"2021","unstructured":"Jackson\u00a0KE, Wang\u00a0L, Casey\u00a0JD et\u00a0al (2021) Effect of early balanced crystalloids before ICU admission on sepsis outcomes. Chest 159:585\u2013595. https:\/\/doi.org\/10.1016\/j.chest.2020.08.2068","journal-title":"Chest"},{"key":"1354_CR42","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong\u00a0E, van Oers\u00a0JA, Beishuizen\u00a0A et al (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a\u00a0randomised, controlled, open-label trial. Lancet Infect Dis 16:819\u2013827. https:\/\/doi.org\/10.1016\/S1473-3099(16)00053-0","journal-title":"Lancet Infect Dis"},{"key":"1354_CR43","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jinf.2013.10.015","volume":"68","author":"AJ Kaasch","year":"2014","unstructured":"Kaasch\u00a0AJ, Barlow\u00a0G, Edgeworth\u00a0JD et\u00a0al (2014) Staphylococcus aureus bloodstream infection: a\u00a0pooled analysis of five prospective, observational studies. J\u00a0Infect 68:242\u2013251. https:\/\/doi.org\/10.1016\/j.jinf.2013.10.015","journal-title":"J Infect"},{"key":"1354_CR44","doi-asserted-by":"publisher","unstructured":"Kalil AC, Gilbert DN, Winslow DL, Infectious Diseases Society of America et\u00a0al (IDSA) position statement: why IDSA did not endorse the surviving sepsis campaign guidelines. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/cix997","DOI":"10.1093\/cid\/cix997"},{"key":"1354_CR45","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1055\/a-0653-7826","volume":"143","author":"A Kimmig","year":"2018","unstructured":"Kimmig\u00a0A, Weis\u00a0S, Hagel\u00a0S et al (2018) Infektiologische Konsile bei Patienten mit Staphylococcus-aureus-Bakteri\u00e4mie \u2013 eine retrospektive Beobachtungsstudie am Universit\u00e4tsklinikum. Jena DMW \u2013 Dtsch Med Wochenschr 143:e179\u2013e187. https:\/\/doi.org\/10.1055\/a-0653-7826","journal-title":"Jena DMW \u2013 Dtsch Med Wochenschr"},{"key":"1354_CR46","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1056\/NEJMoa1714919","volume":"379","author":"M Krag","year":"2018","unstructured":"Krag\u00a0M, Marker\u00a0S, Perner\u00a0A et\u00a0al (2018) Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. N\u00a0Engl J Med 379:2199\u20132208. https:\/\/doi.org\/10.1056\/NEJMoa1714919","journal-title":"N Engl J Med"},{"key":"1354_CR47","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1378\/chest.09-0087","volume":"136","author":"A Kumar","year":"2009","unstructured":"Kumar\u00a0A, Ellis\u00a0P, Arabi\u00a0Y et\u00a0al (2009) Initiation of inappropriate antimicrobial therapy results in a\u00a0fivefold reduction of survival in human septic shock. Chest 136:1237\u20131248. https:\/\/doi.org\/10.1378\/chest.09-0087","journal-title":"Chest"},{"key":"1354_CR48","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1128\/JCM.01555-07","volume":"45","author":"A Lee","year":"2007","unstructured":"Lee\u00a0A, Mirrett\u00a0S, Reller\u00a0LB, Weinstein\u00a0MP (2007) Detection of bloodstream infections in adults: how many blood cultures are needed? J\u00a0Clin Microbiol 45:3546\u20133548. https:\/\/doi.org\/10.1128\/JCM.01555-07","journal-title":"J Clin Microbiol"},{"key":"1354_CR49","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1128\/jcm.32.11.2829-2831.1994","volume":"32","author":"J Li","year":"1994","unstructured":"Li\u00a0J, Plorde\u00a0JJ, Carlson\u00a0LG (1994) Effects of volume and periodicity on blood cultures. J\u00a0Clin Microbiol 32:2829\u20132831","journal-title":"J Clin Microbiol"},{"key":"1354_CR50","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu\u00a0C, Bayer\u00a0A, Cosgrove\u00a0SE et al (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant staphylococcus aureus infections in adults and children. Clin Infect Dis Off Publ Infect Dis Soc Am 52:e18\u2013e55. https:\/\/doi.org\/10.1093\/cid\/ciq146","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"1354_CR51","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa1101549","volume":"364","author":"K Maitland","year":"2011","unstructured":"Maitland\u00a0K, Kiguli\u00a0S, Opoka\u00a0RO et\u00a0al (2011) Mortality after fluid bolus in african children with severe infection. N\u00a0Engl J Med 364:2483\u20132495. https:\/\/doi.org\/10.1056\/NEJMoa1101549","journal-title":"N Engl J Med"},{"key":"1354_CR52","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1128\/JCM.39.1.274-278.2001","volume":"39","author":"VB Malgrange","year":"2001","unstructured":"Malgrange\u00a0VB, Escande\u00a0MC, Theobald\u00a0S (2001) Validity of earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for diagnosing catheter-related bacteremia in cancer patients. J\u00a0Clin Microbiol 39:274\u2013278. https:\/\/doi.org\/10.1128\/JCM.39.1.274-278.2001","journal-title":"J Clin Microbiol"},{"key":"1354_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1473-3099(12)70311-0","volume":"13","author":"PE Marik","year":"2013","unstructured":"Marik\u00a0PE (2013) Drotrecogin alfa (activated) in severe sepsis. Lancet Infect Dis 13:107. https:\/\/doi.org\/10.1016\/S1473-3099(12)70311-0","journal-title":"Lancet Infect Dis"},{"key":"1354_CR54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00134-016-4675-y","volume":"43","author":"PE Marik","year":"2017","unstructured":"Marik\u00a0PE, Linde-Zwirble\u00a0WT, Bittner\u00a0EA et al (2017) Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a\u00a0large national database. Intensive Care Med 43:625\u2013632. https:\/\/doi.org\/10.1007\/s00134-016-4675-y","journal-title":"Intensive Care Med"},{"key":"1354_CR55","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1056\/NEJMoa2202707","volume":"386","author":"TS Meyhoff","year":"2022","unstructured":"Meyhoff\u00a0TS, Hjortrup\u00a0PB, Wetterslev\u00a0J et\u00a0al (2022) Restriction of intravenous fluid in ICU patients with septic shock. N\u00a0Engl J Med 386:2459\u20132470. https:\/\/doi.org\/10.1056\/NEJMoa2202707","journal-title":"N Engl J Med"},{"key":"1354_CR56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jcrc.2016.04.011","volume":"35","author":"C Moeller","year":"2016","unstructured":"Moeller\u00a0C, Fleischmann\u00a0C, Thomas-Rueddel\u00a0D et al (2016) How safe is gelatin? A\u00a0systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J\u00a0Crit Care 35:75\u201383. https:\/\/doi.org\/10.1016\/j.jcrc.2016.04.011","journal-title":"J Crit Care"},{"key":"1354_CR57","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jama.2023.10598","volume":"330","author":"G Monti","year":"2023","unstructured":"Monti\u00a0G, Bradi\u0107\u00a0N, Marzaroli\u00a0M et\u00a0al (2023) Continuous vs intermittent meropenem administration in critically ill patients with sepsis: the MERCY randomized clinical trial. JAMA 330:141\u2013151. https:\/\/doi.org\/10.1001\/jama.2023.10598","journal-title":"JAMA"},{"key":"1354_CR58","unstructured":"NHS England Sepsis guidance implementation advice for adults."},{"key":"1354_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1164\/rccm.201505-1019OC","volume":"193","author":"R Panwar","year":"2016","unstructured":"Panwar\u00a0R, Hardie\u00a0M, Bellomo\u00a0R et\u00a0al (2016) Conservative versus liberal oxygenation targets for mechanically ventilated patients. A\u00a0pilot multicenter randomized controlled trial. Am J Respir Crit Care Med 193:43\u201351. https:\/\/doi.org\/10.1164\/rccm.201505-1019OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1354_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13054-022-04298-1","volume":"27","author":"E Pardo","year":"2023","unstructured":"Pardo\u00a0E, Lescot\u00a0T, Preiser\u00a0J\u2011C et al (2023) Association between early nutrition support and 28-day mortality in critically ill patients: the FRANS prospective nutrition cohort study. Crit Care 27:7. https:\/\/doi.org\/10.1186\/s13054-022-04298-1","journal-title":"Crit Care"},{"key":"1354_CR61","first-page":"082","volume-title":"S2k Leitlinie Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen \u2013 Update 2018","author":"Paul-Ehrlich-Gesellschaft f\u00fcr Chemotherapie e.\u202fV. (PEG)","year":"2017","unstructured":"Paul-Ehrlich-Gesellschaft f\u00fcr Chemotherapie e.\u202fV. (PEG) (2017) S2k Leitlinie Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen \u2013 Update 2018. AWMF, Registernummer, S 82\u20136"},{"key":"1354_CR62","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","volume":"370","author":"DM Yealy","year":"2014","unstructured":"ProCESS Investigators, Yealy\u00a0DM, Kellum\u00a0JA et al (2014) A randomized trial of protocol-based care for early septic shock. N\u00a0Engl J Med 370:1683\u20131693. https:\/\/doi.org\/10.1056\/NEJMoa1401602","journal-title":"N Engl J Med"},{"key":"1354_CR63","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","volume":"366","author":"VM Ranieri","year":"2012","unstructured":"Ranieri\u00a0VM, Thompson\u00a0BT, Barie\u00a0PS et\u00a0al (2012) Drotrecogin alfa (activated) in adults with septic shock. N\u00a0Engl J Med 366:2055\u20132064. https:\/\/doi.org\/10.1056\/NEJMoa1202290","journal-title":"N Engl J Med"},{"key":"1354_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00092-9","author":"J Reignier","year":"2023","unstructured":"Reignier\u00a0J, Plantefeve\u00a0G, Mira\u00a0J\u2011P et al (2023) Low versus standard calorie and protein feeding in ventilated adults with shock: a\u00a0randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3). Lancet Respir Med. https:\/\/doi.org\/10.1016\/S2213-2600(23)00092-9","journal-title":"Lancet Respir Med"},{"key":"1354_CR65","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00134-016-4665-0","volume":"43","author":"A Reintam Blaser","year":"2017","unstructured":"Reintam Blaser\u00a0A, Starkopf\u00a0J, Alhazzani\u00a0W et\u00a0al (2017) Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med 43:380\u2013398. https:\/\/doi.org\/10.1007\/s00134-016-4665-0","journal-title":"Intensive Care Med"},{"key":"1354_CR66","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes\u00a0A, Evans\u00a0LE, Alhazzani\u00a0W et\u00a0al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304\u2013377. https:\/\/doi.org\/10.1007\/s00134-017-4683-6","journal-title":"Intensive Care Med"},{"key":"1354_CR67","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/antibiotics10060687","volume":"10","author":"DC Richter","year":"2021","unstructured":"Richter\u00a0DC, Dietrich\u00a0M, Lalev\u00a0LD et al (2021) Prolonged infusion of \u03b2\u2011Lactams decreases mortality in patients with septic shock: a\u00a0retrospective before-and-after. Study Antibiot Basel Switz 10:687. https:\/\/doi.org\/10.3390\/antibiotics10060687","journal-title":"Study Antibiot Basel Switz"},{"key":"1354_CR68","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s15010-019-01352-z","volume":"47","author":"DC Richter","year":"2019","unstructured":"Richter\u00a0DC, Frey\u00a0O, R\u00f6hr\u00a0A et al (2019) Therapeutic drug monitoring-guided continuous infusion of piperacillin\/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a\u00a0retrospective analysis of four years of clinical experience. Infection 47:1001\u20131011. https:\/\/doi.org\/10.1007\/s15010-019-01352-z","journal-title":"Infection"},{"key":"1354_CR69","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"E Rivers","year":"2001","unstructured":"Rivers\u00a0E, Nguyen\u00a0B, Havstad\u00a0S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N\u00a0Engl J Med 345:1368\u20131377. https:\/\/doi.org\/10.1056\/NEJMoa010307","journal-title":"N Engl J Med"},{"key":"1354_CR70","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13017-017-0132-7","volume":"12","author":"M Sartelli","year":"2017","unstructured":"Sartelli\u00a0M, Catena\u00a0F, Abu-Zidan\u00a0FM et al (2017) Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emerg Surg 12:22. https:\/\/doi.org\/10.1186\/s13017-017-0132-7","journal-title":"World J Emerg Surg."},{"key":"1354_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s00104-019-0795-6","author":"T Schmoch","year":"2019","unstructured":"Schmoch\u00a0T, Al-Saeedi\u00a0M, Hecker\u00a0A et al (2019) Evidence-based interdisciplinary treatment of abdominal sepsis. Chir Z Alle Geb Oper Medizen. https:\/\/doi.org\/10.1007\/s00104-019-0795-6","journal-title":"Chir Z Alle Geb Oper Medizen"},{"key":"1354_CR72","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10049-018-0515-7","volume":"22","author":"T Schmoch","year":"2019","unstructured":"Schmoch\u00a0T, Bernhard\u00a0M, Siegler\u00a0BH et\u00a0al (2019) H\u00e4modynamische Stabilisierung des septischen Patienten in der Notaufnahme. Notf Rettungsmedizin 22:205\u2013218. https:\/\/doi.org\/10.1007\/s10049-018-0515-7","journal-title":"Notf Rettungsmedizin"},{"key":"1354_CR73","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1055\/s-0044-100989","volume":"14","author":"T Schmoch","year":"2018","unstructured":"Schmoch\u00a0T, Bernhard\u00a0M, Uhle\u00a0F et\u00a0al (2018) Neue Definitionen der Sepsis. Intensivmed Up2date 14:371\u2013389. https:\/\/doi.org\/10.1055\/s-0044-100989","journal-title":"Intensivmed Up2date"},{"key":"1354_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-021-00916-9","author":"T Schmoch","year":"2021","unstructured":"Schmoch\u00a0T, Brenner\u00a0T, Becker-Pennrich\u00a0A et al (2021) Therapie der Sepsis-induzierten Koagulopathie. Ergebnisse einer deutschlandweiten Umfrage auf Intensivstationen. Anaesthesist. https:\/\/doi.org\/10.1007\/s00101-021-00916-9","journal-title":"Anaesthesist"},{"key":"1354_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-021-01011-9","author":"T Schmoch","year":"2021","unstructured":"Schmoch\u00a0T, Brenner\u00a0T, Becker-Pennrich\u00a0A et al (2021) Praxis der medikament\u00f6sen Thromboseprophylaxe und Antikoagulation bei Patienten mit Sepsis und vorbestehender Antikoagulation oder Heparin-induzierter Thrombozytopenie Typ\u00a0II \u2013 Ergebnisse einer deutschlandweiten Umfrage auf Intensivstationen. Anaesthesist. https:\/\/doi.org\/10.1007\/s00101-021-01011-9","journal-title":"Anaesthesist"},{"key":"1354_CR76","doi-asserted-by":"publisher","DOI":"10.19224\/ai2022.123","author":"T Schmoch","year":"2022","unstructured":"Schmoch\u00a0T, Brenner\u00a0T, Weigand\u00a0MA (2022) Neue internationale Sepsis-Leitlinien 2021 \u2013 Was ist neu \u2013 was bleibt gleich? 2021 update of the Surviving Sepsis Campaign guidelines \u2013 What is new, what remains unchanged? An\u00e4sth Intensiv. https:\/\/doi.org\/10.19224\/ai2022.123","journal-title":"An\u00e4sth Intensiv"},{"key":"1354_CR77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13613-022-01093-7","volume":"13","author":"T Schmoch","year":"2023","unstructured":"Schmoch\u00a0T, M\u00f6hnle\u00a0P, Weigand\u00a0MA et al (2023) The prevalence of sepsis-induced coagulopathy in patients with sepsis\u2014a\u00a0secondary analysis of two German multicenter randomized controlled trials. Ann Intensive Care 13:3. https:\/\/doi.org\/10.1186\/s13613-022-01093-7","journal-title":"Ann Intensive Care"},{"key":"1354_CR78","first-page":"74","volume":"11","author":"T Schmoch","year":"2020","unstructured":"Schmoch\u00a0T, Richter\u00a0D, Heininger\u00a0A et\u00a0al (2020) Optimierte (Erreger\u2011) Diagnostik in der Sepsis. DIVI Dtsch Interdiszip Ver F\u00fcr Intensiv. Notfallmedizin 11:74\u201381. https:\/\/doi.org\/10.3238\/DIVI.2020.0074\u20130081","journal-title":"Notfallmedizin"},{"key":"1354_CR79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz\u00a0P, Wirz\u00a0Y, Sager\u00a0R et al (2018) Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a\u00a0patient level meta-analysis. Lancet Infect Dis 18:95\u2013107. https:\/\/doi.org\/10.1016\/S1473-3099(17)30592-3","journal-title":"Lancet Infect Dis"},{"key":"1354_CR80","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1711584","volume":"378","author":"MW Semler","year":"2018","unstructured":"Semler\u00a0MW, Self\u00a0WH, Wanderer\u00a0JP et\u00a0al (2018) Balanced crystalloids versus saline in critically ill adults. N\u00a0Engl J Med 378:829\u2013839. https:\/\/doi.org\/10.1056\/NEJMoa1711584","journal-title":"N Engl J Med"},{"key":"1354_CR81","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour\u00a0CW, Gesten\u00a0F, Prescott\u00a0HC et\u00a0al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N\u00a0Engl J Med 376:2235\u20132244. https:\/\/doi.org\/10.1056\/NEJMoa1703058","journal-title":"N Engl J Med"},{"key":"1354_CR82","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/jama.2023.6483","volume":"330","author":"CN Shappell","year":"2023","unstructured":"Shappell\u00a0CN, Klompas\u00a0M, Rhee\u00a0C (2023) Do prolonged infusions of \u03b2\u2011Lactam antibiotics improve outcomes in critically ill patients with sepsis? JAMA 330:126\u2013128. https:\/\/doi.org\/10.1001\/jama.2023.6483","journal-title":"JAMA"},{"key":"1354_CR83","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer\u00a0M, Deutschman\u00a0CS, Seymour\u00a0CW et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"1354_CR84","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clnu.2018.08.037","volume":"38","author":"P Singer","year":"2019","unstructured":"Singer\u00a0P, Blaser\u00a0AR, Berger\u00a0MM et\u00a0al (2019) ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr Edinb Scotl 38:48\u201379. https:\/\/doi.org\/10.1016\/j.clnu.2018.08.037","journal-title":"Clin Nutr Edinb Scotl"},{"key":"1354_CR85","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.clinmicnews.2015.03.001","volume":"37","author":"J Snyder","year":"2015","unstructured":"Snyder\u00a0J (2015) Blood cultures: the importance of meeting pre-analytical requirements in reducing contamination, optimizing sensitivity of detection, and clinical relevance. Clin Microbiol Newsl 37:53\u201357. https:\/\/doi.org\/10.1016\/j.clinmicnews.2015.03.001","journal-title":"Clin Microbiol Newsl"},{"key":"1354_CR86","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1086\/649554","volume":"50","author":"JS Solomkin","year":"2010","unstructured":"Solomkin\u00a0JS, Mazuski\u00a0JE, Bradley\u00a0JS et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the surgical infection society and the infectious diseases society of america. Clin Infect Dis Off Publ Infect Dis Soc Am 50:133\u2013164. https:\/\/doi.org\/10.1086\/649554","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"1354_CR87","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1473-3099(17)30615-1","volume":"18","author":"KZ Vardakas","year":"2018","unstructured":"Vardakas\u00a0KZ, Voulgaris\u00a0GL, Maliaros\u00a0A et al (2018) Prolonged versus short-term intravenous infusion of antipseudomonal \u03b2\u2011lactams for patients with sepsis: a\u00a0systematic review and meta-analysis of randomised trials. Lancet Infect Dis 18:108\u2013120. https:\/\/doi.org\/10.1016\/S1473-3099(17)30615-1","journal-title":"Lancet Infect Dis"},{"key":"1354_CR88","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"J-L Vincent","year":"2019","unstructured":"Vincent\u00a0J\u2011L, Francois\u00a0B, Zabolotskikh\u00a0I et al (2019) Effect of a\u00a0recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA 321:1993\u20132002. https:\/\/doi.org\/10.1001\/jama.2019.5358","journal-title":"JAMA"},{"key":"1354_CR89","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s00134-022-06648-7","volume":"48","author":"S Yoshihiro","year":"2022","unstructured":"Yoshihiro\u00a0S, Taito\u00a0S (2022) Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin\/tazobactam therapy for patients with sepsis. Intensive Care Med 48:770\u2013771. https:\/\/doi.org\/10.1007\/s00134-022-06648-7","journal-title":"Intensive Care Med"},{"key":"1354_CR90","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.11684","author":"FG Zampieri","year":"2021","unstructured":"Zampieri\u00a0FG, Machado\u00a0FR, Biondi\u00a0RS et\u00a0al (2021) Effect of intravenous fluid treatment with a\u00a0balanced solution vs 0.9\u202f% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial. JAMA. https:\/\/doi.org\/10.1001\/jama.2021.11684","journal-title":"JAMA"},{"key":"1354_CR91","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1001\/jama.2016.5828","volume":"315","author":"A Zarbock","year":"2016","unstructured":"Zarbock\u00a0A, Kellum\u00a0JA, Schmidt\u00a0C et\u00a0al (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315:2190\u20132199. https:\/\/doi.org\/10.1001\/jama.2016.5828","journal-title":"JAMA"},{"key":"1354_CR92","doi-asserted-by":"publisher","unstructured":"(2023) Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension. N Engl J Med 388:499\u2013510. https:\/\/doi.org\/10.1056\/NEJMoa2212663","DOI":"10.1056\/NEJMoa2212663"},{"key":"1354_CR93","unstructured":"(2018) Surviving sepsis campaign | SSC hour\u20111 bundle; webseite heruntergeladen am 04.12.2018. http:\/\/www.survivingsepsis.org\/Bundles\/Pages\/default.aspx (04.\u00a0Dezember)"}],"container-title":["Die Anaesthesiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-023-01354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-023-01354-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-023-01354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T16:03:00Z","timestamp":1705420980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-023-01354-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1354"],"URL":"https:\/\/doi.org\/10.1007\/s00101-023-01354-5","relation":{},"ISSN":["2731-6858","2731-6866"],"issn-type":[{"value":"2731-6858","type":"print"},{"value":"2731-6866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"2 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Schmoch gibt an, dass kein Interessenkonflikt besteht. M.A.\u00a0Weigand berichtet, dass er Vortragshonorare von GE Healthcare (Deutschland), Gilead (Deutschland), K\u00f6hler Chemie (Deutschland), MSD Sharp & Dohme (Deutschland), Pfizer Pharma (Deutschland) und Boehringer Ingelheim (Deutschland) erhalten hat und Mitglied von Beir\u00e4ten bei B. Braun (Deutschland), Gilead (Deutschland), MSD Sharp & Dohme (Deutschland) und Shionogi (Deutschland) war. T.\u00a0Brenner berichtet, dass er Honorare f\u00fcr Vortr\u00e4ge oder Beir\u00e4te erhalten hat: Baxter Deutschland GmbH, Sch\u00f6chl medical education GmbH (Deutschland), Boehringer Ingelheim Pharma GmbH (Deutschland), CSL Behring GmbH (Deutschland), Astellas Pharma GmbH (Deutschland), B.\u00a0Braun Melsungen AG (Deutschland), L\u00fccke Kongresse GmbH (Deutschland), Sedana medical Germany GmbH (Deutschland), Shionogi GmbH (Deutschland) und MSD Sharp & Dohme GmbH (Deutschland) sowie Beirats- und Beratert\u00e4tigkeit f\u00fcr Baxter Deutschland GmbH (Deutschland). Dar\u00fcber hinaus erhielt er Forschungsmittel von der Deutschen Forschungsgemeinschaft (DFG), der Dietmar Hopp Stiftung, dem Innovationsfonds des Gemeinsamen Bundesausschusses (G-BA) und der Stiftung Universit\u00e4tsmedizin Essen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}